Asia Pacific Companion Animal Healthcare Market Overview
Companion animals should be domesticated animals whose emotional, physical, behavioural and social needs can be readily met as companions, or in a close daily relationship with humans in the home. The companies are focusing more on the research for the development of new drugs and vaccines for the exciting and newly diagnosed diseases. Asia Pacific Companion Animal Healthcare Market has seen some of the important mergers and acquisitions to attain expertise in developing new active pharmaceutical ingredients /drugs.
Major drivers that are driving the growth of the market are increased incidence of zoonotic and foodborne diseases, Increasing pet/companion ownership, growing Healthcare concerns of pets, rising demand for improved nutrition. Restrictions by regulatory bodies have a negative impact on the sales of antibiotics, soaring costs and increasing regulations on animal testing have hindered a number of healthcare companies from manufacturing newly advanced drugs are the factors hindering the growth of the market.
Asia Pacific Companion Animal Healthcare Market Forecast Report (2018-2023)
Asia Pacific Companion Animal Healthcare Market was worth USD $2.3 Billion in 2018 and estimated to reach USD $3.12 Billion by the end of 2023 with a growing potential of 6.30 %.
Asia Pacific Companion Animal Healthcare Market Segmentation
based on product type, the market is segmented into Feed additives, Pharmaceuticals, and vaccines. The feed additives segment is further segmented into Nutritional feed additives and Medicinal feed additives. Nutritional feed additives are given to animals for ensuring their growth. Nutritional feed additives include Proteins, minerals, amino acids, and vitamins. On the other hand, medicinal feed additives target particular types of diseases in companion animals. Medicinal feed additives include enzymes, probiotics, hormones, immune modulators, prebiotics, and feed acidifiers. Pharmaceutical products in the Companion animal healthcare market include ectoparasiticides, endectocides, antibiotics, anti-inflammatories, and medicines for curing reproductive problems. Based on Geography, the Asia-Pacific Companion Animal Healthcare market is analysed under various regions namely China, Japan, India and Australia.
Key Developments in the Market:
Major Players:
Reasons to Purchase Asia Pacific Companion Animal Healthcare Market Report
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Feed Additives
5.1.2.1 Nutritional Feed Additives
5.1.2.2 Medicinal Feed Additives
5.1.3 Pharmaceuticals
5.1.4 Vaccines
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Region
6.1.3.2 By Product
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Region
6.1.4.2 By Product
6.1.5 Market Share Analysis
6.1.5.1 By Region
6.1.5.2 By Product
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Pfizer Animal health Ltd
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Merck & Co Inc.
8.3 Sanofi Aventis Animal Health
8.4 Zoetis Inc.
8.5 Boehringer Ingelheim GmbH
8.6 Elanco Products Company
8.7 Bayer AG
8.8 Novartis animal Health Inc.
8.9 Virbac SA
8.10 Ceva Sante Animale
8.11 Vetoquinol SA
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
